ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RON RANKIN M.D.

Geriatric Medicine

48,572

$2.31M

1216
1078 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $60

RAGHAVENDRA PRASAD MD

Geriatric Medicine

37,655

$2.44M

693
524 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $60

JERRY WASSERSTEIN D.O.

Geriatric Medicine

37,162

$2.35M

800
690 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $60

RAJA PASPULA M.D.

Geriatric Medicine

29,845

$2.01M

1183
938 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $60

OHMAR WIN M.D, M.S

Geriatric Medicine

26,568

$1.43M

722
655 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

25%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $60

HATTIE HENDERSON M.D.

Geriatric Medicine

25,519

$1.63M

354
350 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $60

JOSEPH BENENATE D.O.

Geriatric Medicine

23,830

$1.42M

475
348 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $60

EDUARDO CAVEDA MD

Geriatric Medicine

23,325

$1.45M

941
730 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $60

RAMAKRISHNA CHAVA M.D.

Geriatric Medicine

18,493

$1.02M

705
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $60

SUMANT KUMAR M.D.

Geriatric Medicine

18,231

$1.02M

435
372 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $60

SANDRA HAZELIP DO

Geriatric Medicine

13,842

$873K

405
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $60

MILTON GUERRERO M.D.

Geriatric Medicine

13,006

$943K

386
334 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $60

BHARAT LATTHE MD

Geriatric Medicine

12,764

$658K

409
316 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $60

SARAMMA GEORGE M.D.

Geriatric Medicine

12,570

$698K

737
687 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $60

OWEN CAPOCYAN M.D.

Geriatric Medicine

12,475

$831K

460
358 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $60

TERRI ECKERT M.D.

Geriatric Medicine

12,306

$729K

226
204 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $60

CHARLES SMITH D.O.

Geriatric Medicine

11,693

$775K

256
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $60

KURT MERKELZ M.D.

Geriatric Medicine

11,544

$729K

283
261 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $60

MILTON SHAW M.D.

Geriatric Medicine

11,040

$665K

226
202 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $60

PATRICIA ROBERTS D.O.

Geriatric Medicine

9,627

$573K

324
154 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $60

PETER GRAY MD

Geriatric Medicine

9,429

$532K

598
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $60

KIM HIGGINS DO

Geriatric Medicine

9,269

$450K

335
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $60

CHARLES MILLER MD

Geriatric Medicine

8,848

$514K

252
195 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $60

SEEMA MODI MD

Geriatric Medicine

8,578

$609K

501
453 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $60

VIJAYA SUDANAGUNTA M.D.

Geriatric Medicine

8,098

$435K

270
194 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank